|
Policy to expand access to anti-malarial drug treatment in the Papua Region of Indonesia: Who should the target? Mara Ipa, Agung Dwi Laksono, Anis Nur Widayati, Yuneu Yuliasih, Nita Rahayu, Endang Puji Astuti
National Research and Innovation Agency Republic of Indonesia, Jakarta, Indonesia
Abstract
Background: Papua region is hyperendemic and accounts for most nationally registered malaria cases in Indonesia.
Purpose: The study aims to analyze the target to expand accessing anti-malarial drug treatment in Papua Region-Indonesia.
Methods: The study analyzed the 2018 Indonesia Basic Health Survey data. This study^s unit analysis comprised malaria patients over 15, yielding a sample size of 3,434 people. This study looked at age, gender, place of residence, education, occupation, marital status, wealth status, and transportation cost in addition to anti-malarial medicine treatment as a dependent variable.
Results: The result shows that Papuan malaria patients in West Papua Province are 1.812 times more likely than those in Papua Province to get anti-malarial treatment (95%CI 1.262-2.601). Papuan malaria patients in rural areas are 1.490 times more likely than those in urban areas to get anti-malarial treatment (95%CI 1.178-1.885). Meanwhile, the study found education level has no relation to anti-malarial treatment among malaria patients in Papua Region-Indonesia. The farmer is 1.846 times more likely than the non-farmer to get anti-malarial treatment (95%CI 1.356-2.512). The richer are 0.572 less likely to get anti-malarial treatment than the poorest (95%CI 0.418-0.783). Furthermore, the results found transportation cost has no relation to anti-malarial treatment among malaria patients in Papua Region-Indonesia.
Conclusion: The study concludes that specific targets to expand accessing anti-malarial drug treatment in Papua Region-Indonesia are living in Papua Province, living in urban areas, and working as non-farmer.
Keywords: anti-malarial drug, malaria, Papua region, the 2018 Indonesian basic health survey.
Topic: Other Health Science-related Topics
|